Gastric cancer increase the percentage of intermediate (CD14++CD16+) and nonclassical (CD14+CD16+) monocytes

Central-European Journal of Immunology

Volumn 37, Issue 4, 2012, Pages 355-361

  Eljaszewicz, Andrzej ^a   Jankowski, Michal ^a   Gackowska, Lidia ^a   Helmin Basa, Anna ^a   Wiese, Malgorzata ^a   Kubiszewska, Izabela ^a   Kaszewski, Wojciech ^a   Michalkiewicz, Jacek ^a,b   Zegarski, Wojciech ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Flow cytometry; Gastric cancer; IL 10; TNF

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MONOCYTE; PROTEIN BLOOD LEVEL; STOMACH CANCER;

EID: 84875154164     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2012.32725     Document Type: Article

References (29)

1. Gordon S, Taylor PR (2005): Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
2. Ohno S, Inagawa H, Dhar DK, et al. (2003): The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res 23: 5015-5022.
3. Leek RD, Lewis CE, Whitehouse R, et al. (1996): Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996; 56: 4625-4629.
4. Shimura S, Yang G, Ebara S, et al. (2000): Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res 60: 5857-5861.
5. Eljaszewicz A, Gackowska L, Kubiszewska I, et al. (2010): Macrophage activity in tumour development. Wspolczesna Onkol 14: 1-6.
6. Szaflarska A, Siedlar M, Zembala M (2003): Human mono-cytes/macrophages in the antitumour response of the host. Centr Eur J Immunol 28: 88-103.
7. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. (2010): Nomenclature of monocytes and dendritic cells in blood. Blood 116: e74-80.
8. Ziegler-Heitbrock HW (1996): Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today 17: 424-428.
9. Grage-Griebenow E, Flad HD, Ernst M (2001): Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 69: 11-20.
10. Skrzeczynska-Moncznik J, Bzowska M, Loseke S, et al. (2008): Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol 67: 152-159.
11. Nockher WA, Scherberich JE (1998): Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 66: 2782-2790.
12. Katayama K, Matsubara T, Fujiwara M, et al. (2000): CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol 121: 566-570.
13. Fingerle G, Pforte A, Passlick B, et al. (1993): The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82: 3170-3176.
14. Feng AL, Zhu JK, Sun JT, et al. (2011): CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattrac-tant protein-1 and may be useful for early diagnosis. Clin Exp Immunol 164: 57-65.
15. Saleh MN, Goldman SJ, LoBuglio AF, et al. (1995): CD16+ monocytes in patients with cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor. Blood 85: 2910-2917.
16. Belge KU, Dayyani F, Horelt A, et al. (2002): The proinflam-matory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 168: 3536-3542.
17. Ziegler-Heitbrock L (2007): The CD14+ CD16+ blood mono-cytes: their role in infection and inflammation. J Leukoc Biol 81: 584-592.
18. Rivier A, Pène J, Rabesandratana H, et al. (1995): Blood monocytes of untreated asthmatics exhibit some features of tissue macrophages. Clin Exp Immunol 100: 314-318.
19. Skrzeczynska J, Kobylarz K, Hartwich Z, et al. (2002): CD14+CD16+ monocytes in the course of sepsis in neonates and small children: monitoring and functional studies. Scand J Immunol 55: 629-638.
20. Michalkiewicz J, Stachowski J, Barth C, et al. (1998): Effect of Pseudomonas aeruginosa exotoxin A on CD3-induced human T-cell activation. Immunol Lett 61: 79-88.
21. Peters JH, Ruppert J, Gieseler RK, et al. (1991): Differentiation of human monocytes into CD14 negative accessory cells: do dendritic cells derive from the monocytic lineage? Patho-biology 59: 122-126.
22. Randolph GJ, Inaba K, Robbiani DF, et al. (1999): Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11: 753-761.
23. Mantovani A, Sozzani S, Locati M, et al. (2002): Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555.
24. Mroczko B, Wereszczynska-Siemiatkowska U, Groblewska M, et al. (2006): The diagnostic value of hematopoietic cytokines measurement in the sera of gastric cancer and gastric ulcer patients. Clin Chim Acta 374: 165-167.
25. Allavena P, Piemonti L, Longoni D, et al. (1998): IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 28: 359-369.
26. Szaflarska A, Baj-Krzyworzeka M, Siedlar M, et al. (2004): Antitumor response of CD14+/CD16+ monocyte subpopula-tion. Exp Hematol 32: 748-755.
27. Aderem A, Underhill DM (1999): Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17: 593-623.
28. Sugai H, Kono K, Takahashi A, et al. (2004): Characteristic alteration of monocytes with increased intracellular IL-10 and IL-12 in patients with advanced-stage gastric cancer. J Surg Res 116: 277-287.
29. Tamandl D, Bahrami M, Wessner B, et al. (2003): Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity. Shock 20: 224-229.